5 ms·
Would be great if they showed some demonstrations / proof of any kind. DeepMind did great in that respect. I understand they're working on a different problem,
by dkural 9y ago
Would be great if they showed some demonstrations / proof of any kind. DeepMind did great in that respect. I understand they're working on a different problem, but it's been a number of years; usually correct ideas don't take that long to show some promising progress.
- Barrin92 9y agoI'm honestly surprised how willing investors are to throw money at these ML startups that actually show barely any progress.
- qq66 9y ago"Show barely any progress" and "show barely any progress to the public" are very different. I don't have any inside information here, but a lack of public announcements is not proof of anything.
- arjo1 9y agoTheir 2017 paper: https://www.vicarious.com/img/icml2017-schemas.pdf https://www.vicarious.com/img/icml2017-schemas.pdf
- eli_gottlieb 9y agoThat's it? That tells me the same thing I saw when I attended a Vicarious researcher's talk at MIT CSAIL: they're basically reinventing stuff the Bayesian generative modelers in cognitive science have been doing for years, throwing some video-game playing at it, and calling it AI instead of cognitive science. Give me $50mil and I could do a good deal more than that, just because I bother to look stuff up!
- fuelfive 9y agoThere are a few papers up on the site already and some more coming. As a business, publications aren't really the KPIs we prioritize (vs an academic-style lab like DM or OAI).
- dkural 9y agoOut of curiosity, what's the KPI? p.s. I don't think papers qualify as a "demo". I'm with you re: not running it like an academic lab and chasing a minimal publishable unit or fashions of the time. Demo = Demonstrably do something with your technology no one could do before, ie beat people at Go in DeepMinds case, in your case you could set up your own benchmark / pass a Turing test for 3 year olds or something.
- congerous 9y agoKPI = amount of funds raised.
- lumost 9y agoThe economics for some of these labs is also pretty different from what you'd normally expect. There are numerous semi-private organizations in the defense space ( such as Boston Dynamics ) and similarly in the pharmaceutical space. Which may only produce commercially viable technology after a decade or more. For many of these entities, the funding dynamics are dependent on the overall scope of the problem along with the quality of the team rather than any direct foreseeable economic outcome.
- dkural 9y agoI understand, I don't mean commercial progress either.